Infliximab Biosimilar, TNF alpha Monoclonal Antibody. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant...
Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use...
Infliximab biosimilar L234A L235A P329G (LALAPG) Fc silent mutant (anti-human TNF alpha monoclonal antibody) is used for ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and...
Alemtuzumab Biosimilar, Human CD52 Monoclonal Antibody. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Abciximab Biosimilar, Glycoprotein IIb/IIIa Receptor Monoclonal Antibody. The research grade abciximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody. The research grade ramucirumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Etanercept Biosimilar. The research grade etanercept biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls and recombinant hIgG1 Fc proteins are available.
Secukinumab Biosimilar, Human IL17A Monoclonal Antibody. The research grade Secukinumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
